Clinical Trial Update: Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms [Phase 2]

View source ↗

Summary

The Phase 2 safety and efficacy trial of a single dose NA-1 in patients with subarachnoid hemorrhage undergoing endovascular repair for ruptured intracranial an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ruptured Intracranial Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• NA-1

Snippet

Sponsor: NoNO Inc. | Conditions: Subarachnoid Hemorrhage, Ruptured Intracranial Aneurysm | Phase 2 | Status: WITHDRAWN